These findings were consistent with those of Deng and coworkers [159], who revealed that RT plus anti-PD-L1 could synergistically reduce the infiltration of MDSCs which normally suppress the antitumor T cells response, thus altering the immune response in the TME of breast cancer-bearing mouse models. This evidence concerns the gene CD274 and breast carcinoma.